Abiopharma

(99% Neutral) CRYO-CELL INTERNATIONAL, INC. (CCEL) Announces Business Combination

Williams Michelle LeRoux 🟡 adjusted position in 4.6K shares (1 derivative) of ELUTIA INC. (ELUT) at $1.09 Transaction Date: Mar 10, 2026 | Filing ID: 000004

Cryo-Cell Receives NYSE American Continued Listing Notice

The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034

Cryo-Cell Receives NYSE American Continued Listing Notice

NOVAGOLD & Paulson Award Engineering Contracts to WSP, Worley, and Hatch for Key Infrastructure and Unit Operations in Bankable Feasibility Study

Fiverr Files its Annual Report on Form 20-F

Renaming of Index Tracked by Sprott Uranium Miners ETF (URNM)

Parker Scheduled to Present at the Bank of America Global Industrials Conference on March 18 at 10:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time)

Precipio Announces Q4 and year-end 2025 Shareholder Update Call

📋 MIKA NISHIMURA (Director) plans to sell 4K shares of SI-BONE, INC. (at $13.83 each, total $57K) Filed: Mar 12, 2026 | ID: 002554

New Form SCHEDULE 13D/A - Pacira BioSciences, Inc. <b>Filed:</b> 2026-03-12 <b>AccNo:</b> 0001011438-26-000180 <b>Size:</b> 58 KB

TZIANABOS ARTHUR 🟡 adjusted position in 4.4K shares (1 derivative) of Stoke Therapeutics, Inc. (STOK) at $40.00 Transaction Date: Mar 10, 2026 | Filing ID: 000002

CHAMPIONS ONCOLOGY, INC. (CSBR) Files Form 10-Q

Krainer Adrian R. 🔴 sold 33.2K shares of Stoke Therapeutics, Inc. (STOK) at $39.74 ($1.3M) Transaction Date: Mar 10, 2026 | Filing ID: 000004